The path to commercialization for every FDA approved drug and cleared medical device in the United States began with a Clinical Trial. Recruitment of Study Sites, generally Healthcare Organizations (HCO), and Principal Investigators (PI), often healthcare providers (HCP), are fundamental, but often vexing, first steps in starting a clinical trial. Failure to recruit the best Study Sites and PIs for a protocol is second only to inadequate patient recruitment and retention for the failure of Clinical Trials.
Reltio Site Intelligence is a cloud-native platform that enables Pharma R&D Teams and Contract Research Organizations (CRO) to centralize detailed data about Study Sites and PIs, including past performance, ratings, and competitive information, from multiple sources. Making decisions based on Unified, Reliable, Real-Time data can mean the difference between success and failure, profit and loss.